Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Sanofi's Diabetes Drug Faces Scrutiny from FDA

May 24, 2016 10:03 am | by Ryan Bushey, Digital Editor | Articles | Comments

An early review conducted by The Food and Drug Administration (FDA) of Sanofi’s combination diabetes drug iGlarLixi is raising issues related to efficacy.

TOPICS:

Janssen's Stelara Maintained Clinical Remission After Year Of Treatment

May 24, 2016 9:21 am | News | Comments

Janssen Phase 3 data presented for the first time at Digestive Disease Week 2016 showed that a significantly greater proportion of adult patients with moderate to severe Crohn's disease receiving Stelara (ustekinumab) subcutaneous (SC) maintenance therapy were in clinical remission at one year. 

TOPICS:

CDK4/6 Inhibitor Abemaciclib Most Active Against Breast Cancer, NSCLC

May 24, 2016 8:43 am | by Stephanie Guzowski, Editor | News | Comments

New results from a Phase 1 clinical trial that tested Eli Lilly’s investigational CDK4/6 inhibitor indicates that abemaciclib is likely in line to become an FDA-approved CDK4/6 inhibitor.

TOPICS:
Advertisement

Cutting-Edge Findings in Cannabis Research

May 24, 2016 8:42 am | by De Gruyter Open | News | Comments

The recent legalization of cannabis for medical purposes in some US states has reinvigorated the debate over cannabis in Germany. 

TOPICS:

Breast Cancer Drug Discovery Offers Hope for New Treatments

May 24, 2016 8:41 am | by University of Edinburgh | News | Comments

A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.

TOPICS:

Yellow Fever Epidemic Threatens Spread from Angola to China

May 24, 2016 8:39 am | by Elsevier Health Sciences | News | Comments

The spread of yellow fever is a global health threat.

TOPICS:

Catching Metastatic Cancer Cells Before They Grow Into Tumors

May 24, 2016 8:38 am | by Rachel M. Dudek and Lonnie Shea, University of Michigan, The Conversation | News | Comments

“Cure” is a word that’s dominated the rhetoric in the war on cancer for decades.

TOPICS:

GSK Announces Impressive New Data for COPD Drug

May 24, 2016 8:38 am | News | Comments

Analyses remain ongoing and will be the subject of future publications and presentations.

TOPICS:
Advertisement

Astellas, Daiichi Sankyo, and Takeda Announce R&D Collaboration on Biomarker Database

May 23, 2016 2:57 pm | News | Comments

All three firms aim to contribute to the enhancement of health and welfare of people around the world through creating innovative medicine.

TOPICS:

Harvard Licenses Genotyping Platform

May 23, 2016 2:00 pm | by Harvard Gazette | News | Comments

The technology addresses the profound challenge of drug resistance among HIV-infected patients in resource-poor areas.

TOPICS:

One Step Closer to Curing Diabetes

May 23, 2016 1:00 pm | by University of Technology, Sydney | News | Comments

The group is now working with US clinical stage biotechnology company PharmaCyte Biotech to commercialize the research.

TOPICS:

Novartis' Entresto Gains Strong Recommendation for US, EU Heart Failure Guidelines

May 23, 2016 9:48 am | News | Comments

This decision was made less than a year after regulatory approvals. 

TOPICS:

FDA Questions Novo's Phase 3 Data for Diabetes Drug

May 23, 2016 9:07 am | by Ryan Bushey, Digital Editor | Articles | Comments

This drug is projected to be an important source of revenue for Novo Nordisk.

TOPICS:

Breaking Down Cancer Cell Defenses

May 23, 2016 8:52 am | by University of Pennsylvania | News | Comments

The mistaken activation of certain cell-surface receptors contributes to a variety of human cancers.

TOPICS:

France to Tighten Up Drug Trial Rules after Fatal Incident

May 23, 2016 8:48 am | by The Associated Press | News | Comments

France's health minister presented a plan on Monday to tighten the rules regarding human drug trials following an experimental test that killed a volunteer in January.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading